12 years' median follow up (MFU) of BIG 1-98: Adjuvant letrozole, tamoxifen and their sequence for postmenopausal women with endocrine responsive early breast cancer

被引：0
|
作者：
Thuerlimann, B. [1 ,2 ]
Giobbie-Hurder, A.
Colleoni, M.
Jensen, M-B
Ejlertsen, B.
de Azambuja, E.
Neven, P.
Lang, I.
Gladieff, L.
Bonnefoi, H.
Harvey, V. J.
Spazzapan, S.
Tondini, C.
Price, K.
Piccart-Gebhart, M.
Regan, M. M.
Gelber, R. D.
Coates, A. S.
Goldhirsch, A.
机构：
[1] Int Breast Canc Study Grp, Bern, Switzerland
[2] BIG 1 98 Collaborat Grp, Bern, Switzerland
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P2-09-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-09-05
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer:: Update of study BIG 1-98
    Coates, Alan S.
    Keshaviah, Aparna
    Thuerlimann, Beat
    Mouridsen, Henning
    Mauriac, Louis
    Forbes, John F.
    Paridaens, Robert
    Castiglione-Gertsch, Monica
    Gelber, Richard D.
    Colleoni, Marco
    Lang, Istvan
    Del Mastro, Lucia
    Smith, Ian
    Chirgwin, Jacquie
    Nogaret, Jean-Marie
    Pienkowski, Tadeusz
    Wardley, Andrew
    Jakobsen, Erik H.
    Price, Karen N.
    Goldhirsch, Aron
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) : 486 - 492
  • [2] Five years of continuous letrozole versus tamoxifen as adjuvant therapy for postmenopausal women with endocrine-responsive breast cancer:: Further analyses and update of BIG 1-98
    Coates, Alan S.
    Keshaviah, Aparna
    Thuerlimann, Beat
    Mouridsen, Henning
    Mauriac, Louis
    Paridaens, Robert
    Castiglione-Gertsch, Monica
    Gelber, Richard D.
    Smith, Ian
    Goldhirsch, Aron
    ANNALS OF ONCOLOGY, 2006, 17 : 93 - 94
  • [3] BIG 1-98 Update: Evaluating Letrozole and Tamoxifen Alone and in Sequence at 8 Years Median Follow-up for Postmenopausal Women With Steroid Hormone Receptor-Positive Breast Cancer
    Gelber, R. D.
    Thuerlimann, B.
    Giobbie-Hurder, A.
    Mauriac, L.
    Ejlertsen, B.
    Paridaens, R.
    Price, K. N.
    Regan, M. M.
    Coates, A. S.
    Godhirsch, A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S334 - S335
  • [4] Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
    Rabaglio, M.
    Sun, Z.
    Price, K. N.
    Castiglione-Gertsch, M.
    Hawle, H.
    Thurlimann, B.
    Mouridsen, H.
    Campone, M.
    Forbes, J. F.
    Paridaens, R. J.
    Colleoni, M.
    Pienkowski, T.
    Nogaret, J. -M.
    Lang, I.
    Smith, I.
    Gelber, R. D.
    Goldhirsch, A.
    Coates, A. S.
    ANNALS OF ONCOLOGY, 2009, 20 (09) : 1489 - 1498
  • [5] Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial
    Phillips, Kelly-Anne
    Ribi, Karin
    Sun, Zhuoxin
    Stephens, Alisa
    Thompson, Alastair
    Harvey, Vernon
    Thuerlimann, Beat
    Cardoso, Fatima
    Pagani, Olivia
    Coates, Alan S.
    Goldhirsch, Aron
    Price, Karen N.
    Gelber, Richard D.
    Bernhard, Juerg
    BREAST, 2010, 19 (05): : 388 - 395
  • [6] Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer:: The BIG 1-98 trial
    Crivellari, Diana
    Sun, Zhuoxin
    Coates, Alan S.
    Price, Karen N.
    Thuerlimann, Beat
    Mouridsen, Henning
    Mauriac, Louis
    Forbes, John F.
    Paridaens, Robert J.
    Castiglione-Gertsch, Monica
    Gelber, Richard D.
    Colleoni, Marco
    Lang, Istvan
    Del Mastro, Lucia
    Gladieff, Laurence
    Rabaglio, Manuela
    Smith, Ian E.
    Chirgwin, Jacquie H.
    Goldhirsch, Aron
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 1972 - 1979
  • [7] Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8.1 years median follow-up
    Regan, Meredith M.
    Neven, Patrick
    Giobbie-Hurder, Anita
    Goldhirsch, Aron
    Ejlertsen, Bent
    Mauriac, Louis
    Forbes, John F.
    Smith, Ian
    Lang, Istvan
    Wardley, Andrew
    Rabaglio, Manuela
    Price, Karen N.
    Gelber, Richard D.
    Coates, Alan S.
    Thuerlimann, Beat
    LANCET ONCOLOGY, 2011, 12 (12): : 1101 - 1108
  • [8] Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen in the Breast International Group (BIG) 1-98 trial
    Ribi, K. E.
    Phillips, K. A.
    Sun, Z.
    Stephens, A.
    Thompson, A.
    Harvey, V.
    Thuerlimann, B.
    Cardoso, F.
    Coates, A. S.
    Bernhard, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
    Dieter Koeberle
    Beat Thuerlimann
    Breast Cancer Research and Treatment, 2008, 112 (2) : 387 - 387
  • [10] Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
    Dieter Koeberle
    Beat Thuerlimann
    Breast Cancer Research and Treatment, 2007, 105 : 55 - 66
12345